Medica III
Dynamix Pharmaceuticals Ltd.
Proprietary DynamixFitTM technology for metabolic disorder, inflammatory disease, and cancer drug discovery.


PainReform
Reformulated products to enhance efficacy, reduce adverse effects and increase convenience for the treatment of pain.

www.painreform.com


Sol-Gel Technologies (SGT)
Innovative drug delivery solutions for the pharmaceutical and skincare industries, using proprietary technology for microencapsulation in silica.

www.sol-gel.com



NYSE: MDT
Ventor Technologies
Unique aortic valve prosthesis designed for easy, minimally invasive implantation, improved anchoring and superior hemodynamic performance.
Acquired by Medtronic in February 2009.


Regentis
GelrinTM device for cartilage and other tissue repair.

www.regentis.co.il


Endymion
Next generation medical aesthetic devices for skin rejuvenation, wrinkle reduction and skin tightening; Proprietary OnePulseTM and 3DeepTM technologies, provide multilayer, targeted & controlled desired clinical effects.

Batsheva Elran, belran@medicavp.com


Gardia Medical
Specialized catheter-based delivery systems for interventional cardiovascular procedures; Deliver, Lock, and Deploy devices anywhere on any guidewire.

www.gardiamedical.com


Expanding Orthopedics (EOI)
Novel, proprietary, solutions for Spinal Stabilization and Long Bone Fracture Fixation. Product solutions address both previously unsolved surgical problems and underserved markets.

www.exortho.com


GlobeImmune
TarmogenTM therapy to mobilize the immune system for the treatment of cancer and infectious disease.

www.globeimmune.com





NYSE: BSX
Remon Medical Technologies
Cutting edge telemetric technology enables implantable devices to communicate wirelessly with external system, providing physicians with valuable tools to frequently monitor and treat several potential life threatening conditions. Acquired by Boston Scientific Corporation in June 2007.

www.remonmedical.com





Medica I & II



Lumenis
Global leader in medical and aesthetic lasers and light-based technology for treatment of medical and cosmetic conditions.

www.lumenis.com


NASDAQ: ABMD
Impella
Integrated cardiac assist blood pump for interventional cardiology and cardiac surgery. Acquired by ABiomed in April 2005.

www.abiomed.com


SuperDimension
3D navigation systems (CT-guided bronchoscopy) for minimally-invasive diagnosis and treatment of lung disease.

www.superdimension.com




NASDAQ: ANGO
FlowMedica
Minimally invasive intravascular systems for targeted renal therapy. Acquired by AngioDynamics in January 2009.

www.flowmedica.com




TASE: INCR
InterCure
Breakthrough medical devices for non-invasive treatment of cardiovascular and pulmonary diseases.
IPO:TASE:INCR, July 2007.

www.intercure.com


Collgard Biopharmaceuticals
TempostatinTM - novel therapy for cancer, restenosis & fibrosis.

www.collgard.com


NYSE: EK
Orex Computed Radiography Ltd.
Desktop computed radiography: no films, no chemicals, PC based. Acquired by Kodak in March 2005.

www.orex-cr.com






NASDAQCM: AMRND
Ester Neurosciences
New drugs providing a paradigm shift in treatment of neurological disorders. Acquired by Amarin Corporation in December 2007.

www.amarincorp.com


NYSE: EW
Percutaneous Valve Technologies
Revolutionary products for minimally-invasive replacement of heart valves. Acquired by Edwards Life Sciences in February 2004.

www.edwards.com


NASDAQ: MEMY

VTX: ROG
Memory
Developing innovative drugs for the treatment of debilitating central nervous system (CNS) disorders. IPO: NASDAQ: MEMY, April 2004.
Acquired by Roche in December 2008.

www.memorypharma.com


NASDAQNM: XTLB
LSE: XTL
XTL Biopharmaceuticals, Ltd.
Human therapeutic antibodies, and small molecules for Hepatitis B and C & related liver transplants. IPO:LSE: XTL, 2000. NASDAQ: XTLB.

www.xtlbio.com


NYSE: JNJ
AMEX: IMA
Selfcare
Diagnostics products for chronic diseases: World leader in blood glucose monitoring for diabetes. Acquired by J&J.


NEOP.OB
Neoprobe
Technology for disease targeting agents and gamma detecting medical devices designed to provide surgeons with the location of hidden cancer during surgery. Company was subsidiary of NASDAQ: NEOP.OB.

www.neoprobe.com